Peptide-Functionalized Gold Nanoparticles Targeting PD-L1: Design via a Molecular Dynamic Driven Approach and Further

Micaela Giannetti1, Marina Gobbo2, Lucio Litti2

  • 1Department of Chemical Science and Technologies, University of Rome "Tor Vergata", Via della Ricerca Scientifica, 00133Rome, Italy.

Insights

Researchers developed novel theranostic gold nanostructures targeting Programmed Death Ligand-1 (PD-L1) for early cancer detection. Peptide orientation on nanostructures significantly impacts targeting efficiency, demonstrating a new methodology for protein-targeted nanomedicine.

Area of Science:

  • Nanotechnology
  • Oncology
  • Biochemistry

Background:

  • Targeting Programmed Death Ligand-1 (PD-L1), a key immune checkpoint protein, is crucial for developing effective cancer theranostics.
  • Designing nanostructures for precise protein targeting requires understanding how ligand organization affects molecular recognition.

Purpose of the Study:

  • To design and develop theranostic gold nanostructures functionalized with PD-L1-targeting peptides (PTPs).
  • To investigate the impact of peptide sequence, assembly, and orientation on nanostructure targeting efficiency for PD-L1.

Main Methods:

  • Combining structural analysis of the PD-1/PD-L1 interaction interface with molecular dynamics simulations to design peptide sequences.
  • Synthesizing peptide-functionalized gold nanostructures and evaluating their targeting performance against PD-L1-overexpressing breast cancer cells using surface-enhanced Raman scattering (SERS).

Main Results:

  • Peptide sequence and orientation critically influence nanostructure targeting efficacy.
  • Gold nanostructures functionalized with optimized PTPs achieved ~85% targeting of MDA-MB-231 cells, a nearly four-fold improvement over those with random orientation (23%).

Conclusions:

  • The study establishes a computational framework for the rational design of peptide-functionalized nanostructures for protein targeting.
  • This methodology provides insights into peptide monolayer behavior and is adaptable for targeting other proteins beyond PD-L1.

Related Concept Videos